InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（17 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
17
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Versant Venture Capital VI, L.P.. Director active across 10 companies, notably LENZ Therapeutics, Inc.. In total, 28 reports have been published. Breakdown: 0 buy · 17 sells. Total volume traded: €57.7m. History available since 12 May 2021. The latest transaction was disclosed on 30 September 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Versant Venture Capital VI, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报28 总计
49,701 股@ US$45.35470.38% mcap36.6% 占其流量Common StockSEC:0001193125-25-228493:0
2,370,533 股@ US$1.401487.6% 占其流量Common StockSEC:0001193125-25-213445:0
49,479 股@ US$41.59085.5% 占其流量Common StockSEC:0001193125-25-211363:0
307,707 股@ US$1.533250.0% 占其流量Common StockSEC:0001193125-25-207677:0
20,493 股@ US$40.02970.14% mcap13.4% 占其流量Common StockSEC:0000950170-25-111529:0
145,051 股@ US$39.5016.5% 占其流量Common StockSEC:0000950170-25-110163:0
191,376 股@ US$34.0022.3% 占其流量Common StockSEC:0000950170-25-095616:0
200,000 股@ US$30.46527.0% 占其流量Common StockSEC:0000950170-25-092373:0
100,000 股@ US$29.9518.5% 占其流量Common StockSEC:0000950170-25-088604:0
350,000 股@ US$29.0077.2% 占其流量Common StockSEC:0000950170-25-085490:0
89,990 股@ US$9.65937.8% 占其流量Common StockSEC:0000950170-24-119051:0
1,132,566 股@ US$6.529663.8% 占其流量Common StockSEC:0000950170-24-109112:0
541,897 股@ US$6.0028.4% 占其流量Common StockSEC:0000950170-24-106532:0
221,600 股@ US$6.3202100.0% 占其流量Common StockSEC:0000950170-24-102354:0
400,000 股@ US$1.3501100.0% 占其流量Common StockSEC:0000950170-24-095675:0
391,785 股Class A Common StockSEC:0000899243-24-000269:0
598,203 股Common StockSEC:0000950170-24-035951:0
2,236,888 股Common StockSEC:0000899243-23-000677:0
550,000 股@ US$13.0302100.0% 占其流量Common StockSEC:0000899243-22-028388:0
178,996 股0Common StockSEC:0000899243-22-004169:0
200,213 股0Common StockSEC:0000899243-22-001360:0
371,004 股0Common StockSEC:0000899243-21-049938:0
200,213 股0Common StockSEC:0000899243-21-049594:0
303,614 股@ US$14.632750.0% 占其流量Common StockSEC:0000899243-21-040777:0
12,343,727 股Common StockSEC:0000899243-21-027018:0
28 条申报中的 25 条
About Versant Venture Capital VI, L.P.
Versant Venture Capital VI, L.P. is a declarant with 28 filings in total. Across the 28 sampled filings, all are sells, for sell volume of EUR 57742582, between 2021-05-14 and 2025-10-02. The companies involved include LENZ Therapeutics, Inc., Oyster Point Pharma, Inc., Monte Rosa Therapeutics, Inc., Century Therapeutics, Inc., LAVA Therapeutics NV, and Black Diamond Therapeutics, Inc.
